November 21st 2024
Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
Emerging Insights on MRI-Guided Transurethral Ultrasound Ablation for Prostate Cancer
March 21st 2024For men with prostate cancer, the use of MRI-guided transurethral ultrasound ablation (TULSA) led to a 92 percent decrease in median prostate volume at one year, according to new research recently presented at Society of Interventional Radiology (SIR) conference.
Study: PET/MRI May Prevent Up to 83 Percent of Unnecessary Biopsies in Men with PI-RADS 3 Lesions
March 15th 2024For men with PI-RADS 3 lesions, PRIMARY scores of 4-5 with PET/MRI had a sensitivity rate of 87.5 percent for clinically significant prostate cancer, according to newly published research.
Study Says Low-Field MRI Offers Sufficient Diagnostic Quality for Detecting Spinal Pathology
March 11th 2024In a study of patients who had lumbar spine MRI exams at 0.55T, 1.5T and 3T, researchers found that 0.55T MRI provided acceptable diagnostic quality across all sequences for varying pathologies including degenerative joint disease, compression fractures and osseous metastatic disease.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.
Can Non-Contrast Abbreviated MRI be a Viable Alternative for HCC Surveillance?
February 27th 2024A new meta-analysis noted pooled sensitivity and specificity rates of 83 percent and 91 percent, respectively, for the use of non-contrast abbreviated MRI in surveillance of hepatocellular carcinoma (HCC).
Moving Beyond Mammography for Screening and Staging of Invasive Lobular Carcinoma
February 16th 2024For women with dense breasts, only 25 percent of breast radiologists are confident in the use of mammography for diagnosing invasive lobular carcinoma, according to newly published survey results from the Society of Breast Imaging.
Can Combination of mpMRI and Extracellular Vesicle-Based Biomarkers Enhance csPCa Detection?
January 29th 2024A multivariable model that includes mpMRI and blood testing assessment of prostate extracellular vesicles had a significantly higher AUC and sensitivity rate than mpMRI alone for predicting clinically significant prostate cancer, according to research presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU).
Study Shows BPE Quantification on MRI Helps Predict Risk of Breast Cancer Recurrence
January 24th 2024Researchers found that several measurements of background parenchymal enhancement (BPE) on dynamic contrast-enhanced MRI were linked to a 27 to 66 percent higher risk of breast cancer recurrence.
Claustrophobia in Magnetic Resonance Imaging: An Analysis of Causes, Impacts and Solutions
January 18th 2024Given the frequent challenges in magnetic resonance imaging that are associated with claustrophobia, this author discusses innovations in noise reduction, radiofrequency coils and wide bore scanners, and emphasizes keys to relieving patient anxiety.
Study: Abbreviated MRI and DBT Offer Comparable Breast Cancer Detection in Dense Breasts
January 17th 2024For women with dense breasts, abbreviated breast MRI and digital breast tomosynthesis (DBT) both offered greater than 98 percent sensitivity rates and greater than 94 percent negative predictive values (NPVs) for breast cancer detection, according to newly published research.